Related references
Note: Only part of the references are listed.Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction
Katrina A. Harmon et al.
MICROSCOPY AND MICROANALYSIS (2022)
Autophagy and the Bone Marrow Microenvironment: A Review of Protective Factors in the Development and Maintenance of Multiple Myeloma
Kamron R. Hamedi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance
Rana Muhammad Usman et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma
Nicholas Nikesitch et al.
CELLS (2021)
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Alisha Ramos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Tumor SuppressorPTENas Molecular Switch Node Regulating Cell Metabolism and Autophagy: Implications in Immune System and Tumor Microenvironment
Saveria Aquila et al.
CELLS (2020)
Targeting autophagy to overcome drug resistance: further developments
Haocai Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer
Yuanliang Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The role of CXCR4 in multiple myeloma: Cells' journey from bone marrow to beyond
Tomalika Rahmat Ullah
JOURNAL OF BONE ONCOLOGY (2019)
Autophagy: A novel mechanism of chemoresistance in cancers
Xinyu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Andrew J. Cowan et al.
JAMA ONCOLOGY (2018)
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
Xing Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma
V Desantis et al.
TRANSLATIONAL ONCOLOGY (2018)
HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer
Chih-Yang Huang et al.
CELL DEATH & DISEASE (2018)
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma
Praful Ravi et al.
BLOOD CANCER JOURNAL (2018)
The mammalian ULK1 complex and autophagy initiation
Maria Zachari et al.
SIGNALLING MECHANISMS IN AUTOPHAGY (2017)
mTORC1 as the main gateway to autophagy
Yoana Rabanal-Ruiz et al.
SIGNALLING MECHANISMS IN AUTOPHAGY (2017)
Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1)
Shusaku Shibutani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma
Da Gao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
HMGB1/RAGE axis promotes autophagy and protects keratinocytes from ultraviolet radiation-induced cell death
Kuanhou Mou et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
Caterina Musolino et al.
MEDIATORS OF INFLAMMATION (2017)
Endoplasmic reticulum stress induces autophagy and apoptosis while inhibiting proliferation and drug resistance in multiple myeloma through the PI3K/Akt/mTOR signaling pathway
Yun-Feng Fu et al.
ONCOTARGET (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The novel autophagy inhibitor elaiophylin exerts antitumor activity against multiple myeloma with mutant TP53 in part through endoplasmic reticulum stress-induced apoptosis
Gaoxiang Wang et al.
CANCER BIOLOGY & THERAPY (2017)
Molecular mechanisms in multiple myeloma drug resistance
Nicholas Nikesitch et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
M. A. Frassanito et al.
LEUKEMIA (2016)
Autophagy as a target for hematological malignancy therapy
Zhiwu Dong et al.
BLOOD REVIEWS (2016)
Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway
Leopold F. Froehlich et al.
CANCER CELL INTERNATIONAL (2016)
Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo
Vidal Jarauta et al.
CANCER LETTERS (2016)
Autophagy in Plasma Cell Ontogeny and Malignancy
Enrico Milan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
Katarzyna Baranowska et al.
ONCOTARGET (2016)
Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
Mridul Roy et al.
THERANOSTICS (2016)
Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways
Jianbin Zhang et al.
AUTOPHAGY (2015)
Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma
Megan Y. Murray et al.
CELL CYCLE (2015)
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi et al.
EMBO JOURNAL (2015)
Plasma cell leukemia: from biology to treatment
Tomas Jelinek et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Pharmacologic agents targeting autophagy
Helin Valcifahmetoglu-Norberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance
Li Wang et al.
ONCOLOGY REPORTS (2015)
Cellular and metabolic functions for autophagy in cancer cells
Candia M. Kenific et al.
TRENDS IN CELL BIOLOGY (2015)
KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models
Irene Riz et al.
ONCOTARGET (2015)
Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells
Shota Moriya et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia
A. R. Sehgal et al.
LEUKEMIA (2015)
Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent
Vidula Sukhatme et al.
ECANCERMEDICALSCIENCE (2015)
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Katherine R. Parzych et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
HMGB1-dependent and -independent autophagy
Xiaofang Sun et al.
AUTOPHAGY (2014)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Combined MTOR and autophagy inhibition Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Combined autophagy and proteasome inhibition A phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma
Dan T. Vogl et al.
AUTOPHAGY (2014)
To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate
Douglas R. Green et al.
CELL (2014)
Histone deacetylase inhibitors and cell death
Jing Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Patterns of Relapse or Progression After Bortezomib-Based Salvage Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Jae-Sook Ahn et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2014)
Autophagy and human disease: emerging themes
Jaime L. Schneider et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib
Manuela Gambella et al.
HAEMATOLOGICA (2014)
Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF-κB-Dependent Autophagy
Laura Shulak et al.
JOURNAL OF VIROLOGY (2014)
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Banzhou Pan et al.
MOLECULAR CANCER (2014)
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
Jesus F. San-Miguel et al.
LANCET ONCOLOGY (2014)
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
M. A. Frassanito et al.
LEUKEMIA (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells
Sajjeev Jaganathan et al.
ONCOTARGET (2014)
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
Kim De Veirman et al.
CANCERS (2014)
From structure to metabolism to therapeutic regulation
Mario A. Jardon et al.
AUTOPHAGY (2013)
Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
Ming-Tsang Chiao et al.
AUTOPHAGY (2013)
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma
Maria T. Petrucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Autophagy in Multiple Myeloma: What Makes You Stronger Can Also Kill You
Richard G. Carroll et al.
CANCER CELL (2013)
Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
Laurence Lamy et al.
CANCER CELL (2013)
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
Thomas M. Herndon et al.
CLINICAL CANCER RESEARCH (2013)
Proteasome inhibitors in the treatment of multiple myeloma
Ali McBride et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Proteasome inhibitors in acute leukemia
Denise Niewerth et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells
Shota Moriya et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma
Lisa Vincenz et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Emerging regulation and functions of autophagy
Patricia Boya et al.
NATURE CELL BIOLOGY (2013)
Histone deacetylase 10 promotes autophagy-mediated cell survival
Ina Oehme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HMGB1 Promotes Drug Resistance in Osteosarcoma
Jun Huang et al.
CANCER RESEARCH (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or Autophagy
Yan Zang et al.
CLINICAL CANCER RESEARCH (2012)
Poly(ADP-Ribosyl)ation of High Mobility Group Box 1 (HMGB1) Protein Enhances Inhibition of Efferocytosis
Kasey Davis et al.
MOLECULAR MEDICINE (2012)
Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells
Liangchun Yang et al.
LEUKEMIA & LYMPHOMA (2012)
Blocking Autophagy Prevents Bortezomib-Induced NF-κB Activation by Reducing I-κBα Degradation in Lymphoma Cells
Li Jia et al.
PLOS ONE (2012)
Arsenic Trioxide Exerts Antimyeloma Effects by Inhibiting Activity in the Cytoplasmic Substrates of Histone Deacetylase 6
Xiaoyan Qu et al.
PLOS ONE (2012)
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
Noor Gammoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chaperone-mediated autophagy: a unique way to enter the lysosome world
Susmita Kaushik et al.
TRENDS IN CELL BIOLOGY (2012)
The Role of Atg Proteins in Autophagosome Formation
Noboru Mizushima et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
DAMP-mediated autophagy contributes to drug resistance
Liying Liu et al.
AUTOPHAGY (2011)
Autophagy: Renovation of Cells and Tissues
Noboru Mizushima et al.
CELL (2011)
The Beclin 1 network regulates autophagy and apoptosis
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2011)
In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
Dharminder Chauhan et al.
CLINICAL CANCER RESEARCH (2011)
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2011)
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
D. Chen et al.
CURRENT CANCER DRUG TARGETS (2011)
Emerging therapies for the treatment of relapsed or refractory multiple myeloma
Meletios A. Dimopoulos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Can multiple myeloma become a curable disease?
Jesus F. San-Miguel et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy
Dian J. Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells
Jingyi Li et al.
AUTOPHAGY (2010)
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
Yuan-Ling Liu et al.
AUTOPHAGY (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
mTOR regulation of autophagy
Chang Hwa Jung et al.
FEBS LETTERS (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
Margaret A. Park et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Highly Compacted Chromatin Formed In Vitro Reflects the Dynamics of Transcription Activation In Vivo
Guohong Li et al.
MOLECULAR CELL (2010)
Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
K. Zhu et al.
ONCOGENE (2010)
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
R. J. Shaw
ACTA PHYSIOLOGICA (2009)
Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis
Patricia Balsas et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Role and regulation of autophagy in cancer
Ning Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
A monoclonal gammopathy precedes multiple myeloma in most patients
Brendan M. Weiss et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
Manuela Milani et al.
CANCER RESEARCH (2009)
The Double-Edged Sword of Autophagy Modulation in Cancer
Eileen White et al.
CLINICAL CANCER RESEARCH (2009)
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
V. Raja Solomon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
The role of autophagy in tumour development and cancer therapy
Mathias T. Rosenfeldt et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes
Anne Simonsen et al.
JOURNAL OF CELL BIOLOGY (2009)
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Chang Hwa Jung et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy
Wen-Xing Ding et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effect of autophagy on multiple myeloma cell viability
Bao Hoang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The role of TOR in autophagy regulation from yeast to plants and mammals
Sandra Diaz-Troya et al.
AUTOPHAGY (2008)
Inhibition of histone deacetylase1 induces autophagy
Meeyeon Oh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway
A. Hrzenjak et al.
JOURNAL OF PATHOLOGY (2008)
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
In Hye Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bortezomib for the treatment of mantle cell lymphoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2007)
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy
Serhiy Pankiv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability
Wen-Xing Ding et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Crystal structure of the Bcl-XL-beclin 1 peptide complex -: Beclin 1 is a novel BH3-only protein
Adam Oberstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
Laurence Catley et al.
BLOOD (2006)
Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG
Chengyu Liang et al.
NATURE CELL BIOLOGY (2006)
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Kurt Degenhardt et al.
CANCER CELL (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Another way to die: autophagic programmed cell death
Y Tsujimoto et al.
CELL DEATH AND DIFFERENTIATION (2005)
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
S Wuillème-Toumi et al.
LEUKEMIA (2005)
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
T Hideshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting apoptosis pathways in cancer therapy
IM Ghobrial et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
The molecular machinery of autophagy: unanswered questions
DJ Klionsky
JOURNAL OF CELL SCIENCE (2005)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Determination of four sequential stages during microautophagy in vitro
JB Kunz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets
G Kwon et al.
DIABETES (2004)
Targeting the molecular target of rapamycin (mTOR)
EK Rowinsky
CURRENT OPINION IN ONCOLOGY (2004)
PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells
S Lentzsch et al.
LEUKEMIA (2004)
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis
S Le Gouill et al.
BLOOD (2004)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells
M Jourdan et al.
ONCOGENE (2003)
Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells -: Regulation during interleukin-6 (IL-6)-induced growth and survival
H Spets et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cell biology - Autophagy as a regulated pathway of cellular degradation
DJ Klionsky et al.
SCIENCE (2000)
Share Paper
